期刊文献+

MODS患者血清铜蓝蛋白测定的意义 被引量:1

Significance of detection of serum ceruloplasmin in diagnosis of MODS patients
原文传递
导出
摘要 目的探讨血清中铜蓝蛋白动态变化对多器官功能障碍综合症(MODS)患者早期诊断和病因判断的价值。方法于入院当天分别检测60例MODS患者(MODS组)、30例非MODS患者(对照组)血清铜蓝蛋白(CP)、超敏C反应蛋白(CRCP)、α-酸性糖蛋白(AAG)的含量,并对入选的住院患者进行APACHEⅡ和MODS评分。结果MODS组与对照组相比其APACHEⅡ、MODS评分、血清铜蓝蛋白(CP)、超敏C反应蛋白(CRCP)、α-酸性糖蛋白(AAG)的比较,差异有统计学意义(P<0.05)。非感染组与感染组相比较,铜蓝蛋白与超敏C反应蛋白均明显升高,差异有统计学意义(P<0.05)。结论 MODS患者铜蓝蛋白、超敏C反应蛋白、α-酸性糖蛋白的检测有助于MODS早期诊断;铜蓝蛋白及超敏C反应蛋白的监测有助于MODS病因的初步判断。 Objective To investigate the significance of dynamic changes of serum ceruloplasmin in multiple organ dysfunction syndrome(MODS)for early diagnosis and treatment of the cases.Methods The levels of serum ceruloplasmin(CP),high-sensitivity C-reactive protein(CRCP),α-acid glycoprotein(AAG in 60 MODS patients,MODS group)on the day of admission and 30 cases of non-MODS patients(control group)were determined and analyzed.The APACHE Ⅱ,MODS score were compared between two groups.Results The APACHE Ⅱ,MODS score,based on the levels of serum ceruloplasmin,high-sensitivity C-reactive protein and α-acid glycoprotein in MODS group were significantly different compared to the control group(P0.05).Compared with non-infection group,ceruloplasmin and C-reactive protein were significantly increased,the difference was significant(P0.05).Conclusion In MODS patients,ceruloplasmin and C-reactive protein test can help early diagnose the syndrome;ceruloplasmin and C-reactive protein monitoring also can help determine the cause of MODS useful for guiding treatment of MODS patients.
出处 《中国热带医学》 CAS 2012年第3期336-337,共2页 China Tropical Medicine
基金 海南省卫生厅重点科研课题(No.琼卫2010重点-01)
关键词 MODS 超敏C反应蛋白(CRCP) 铜蓝蛋白(CP) α-酸性糖蛋白(AAG) MODS High-sensitivity C-reactive protein(CRCP) Ceruloplasmin(CP) α-acid glycoprotein(AAG)
  • 相关文献

参考文献8

  • 1Buckley TA,Gomersall CD,Ramsay SJ.Validation of the multipleorgan dysfunction(MOD)score in critically ill medical and surgical[J].Intensive Care Med,2003,29(12):2216-2222.
  • 2Okajima K.Multiple organ failure associated with severe infection-the molecular mechanism(s)and new therapeutic strategies[J].Nippon Rinsho,2007,65 suppl 3:s619-626.
  • 3王今达,王宝恩.多脏器功能失常综合征(MODS)病情分期诊断及严重程度评分标准(经庐山’95全国危重病急救医学学术会讨论通过)[J].中国危重病急救医学,1995,7(6):346-347. 被引量:1424
  • 4Giannoudis PV,Hildebiand E,Pape HC.Inflammatory serummarkers in patients with multiple trauma:can they predict outcome[J].J Bone Joint Surg,2004,86(3):313-323.
  • 5方立.血清铜蓝蛋白水平与急性冠脉综合征病变程度的关系[J].广东医学,2007,28(8):1258-1259. 被引量:3
  • 6Claudia A,Rosanna S,Patrizio P,et al.Ceruloplasmin/Transferrinsystem is related to clinical status in acute stroke[J].Stroke,2009,40:1282.
  • 7Edeleva NV,Osipova NA,Nemtsova ER,et al.Role of theantioxidant ceruloplasmin in complex intensive therapy for severeposthemorrhagic complications in cancer surgery[J].AnesteziolReanimatol,2005,288(5):44-49.
  • 8Carlo C,Ivo G,John H S.Patterns of correlation of plasma ceruloplasminin sepsis[J].Journal of Surgical Research,2008,144(1):107-110.

二级参考文献12

  • 1高燕,张宁新.急性冠脉综合征伴糖代谢异常患者的临床特点[J].广东医学,2007,28(1):104-106. 被引量:3
  • 2HARRIS Z L,DURLEY A P,MAN T K,et al.Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux[J].Proc Natl Acad Sci USA,1996,96:10 812 -10 817.
  • 3VAIDYA S M,KAMALAKAR P L.Copper and ceruloplasmin levels in serum of women with breast cancer[J].Indian J Med Sci,1998,52:184-187.
  • 4TAKAHASHI N,ORTEL T L,PUTANAM F W.Single-chain structure of human ceruloplasmin:The complete amino acid sequence of the whole molecule[ J ].Proc Natl Acad Sci USA,1984,81:390-394.
  • 5LUZA S C,SPEISKY H C.Liver copper storage and transport during development:implications for cytotoxicity[J].Am J Clin Nutr,1996,63:S812-S820.
  • 6BIANCHINI A,MUSCI G,CALABRESE L.Inhibition of endothelial nitric-oxide synthase by ceruloplasmin[J].J Biol Chem,1999,274:20 265 -20 270.
  • 7PATEL B N,DUNN R J,JEONG S Y,et al.Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury[J].J Neurosci,2002,22:6 578 -6 586.
  • 8COX C,TEKNOS T N,BARRIOS M,et al.The role of coppor suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma[J].Laryngoscope,2001,111:696 -701.
  • 9LEE C M,LO H W,SHAO R P,et al.Selective activation of ceruloplasmin promoter in ovarian tumors:Potential use for gene therapy[J].Cancer Res,2004,64:1 788-1 793.
  • 10INOUE K,AKAIKE T,MIYAMOTO Y,et al.Nitrosothiol formation catalyzed by ceruloplasmin:Implication for cytoprotective mechanism iv vivo[ J ].J Biol Chem,1999,274:27 069 -27 075.

共引文献1423

同被引文献12

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部